Category: press statement – en
September 2023 – Eternygen founder Prof. Birkenfeld published exciting work about pre-diabetes in The Lancet Diabetes & Endocrinology
August 2023 – Eternygen published new data: citrate transporter INDY/NaCT/SLC13A5 as a therapeutic target for kidney diseases
August 2023 – Meet the Eternygen team at the “Aging research and drug discovery meeting” in Copenhagen from 28 Aug to 1 Sep
July 2023 – Prof. Andreas Birkenfeld discusses 10 common prejudices about obesity
March 2023 – Eternygen at BioEuropeSpring conference
October 2022 – Eternygen at BioEurope conference
September 2022 – Grit Zahn presents at TESS Research Foundation’s International Research Conference and biotx.ai in September
August 2022 – Eternygen at the “Aging research and drug discovery meeting” in Copenhagen
August 2022 – Eternygen published new paper on SLC13A5 inhibitors
April 2022 – Andreas Birkenfeld and Dr. Grit Zahn are Guest editing a Special Issue on “I’m Not Dead Yet in Metabolic Regulation”
October 2020 – Eternygen Announces the First Closing of its Series A2 Funding Round
Eternygen Announces the First Closing of its Series A2 Funding Round
April 2020 – Eternygen is presenting at „BioLaunchPad, the company showcase platform of BioTrinity” from 28 April – 1 May 2020.
Eternygen is presenting at „BioLaunchPad, the company showcase platform of BioTrinity” from 28 April – 1 May 2020. Link
March 2020 – Dr. Grit Zahn, Head of Research of Eternygen GmbH presents at the 4th International SLC13A5 Deficiency Research Roundtable of the Tess research foundation in March 2020.
Dr. Grit Zahn, Head of Research of Eternygen GmbH presents at the 4th International SLC13A5 Deficiency Research Roundtable of the […]
February 2020 – Eternygen Presents Data Demonstrating INDY Inhibition as Novel Therapeutic Option in NASH
Eternygen Presents Data Demonstrating INDY Inhibition as Novel Therapeutic Option in NASH Press statement
Meet Eternygen at the Biotech Showcase conference 2020 in San Francisco, CA, USA
Meet Eternygen at the Biotech Showcase conference 2020 in San Francisco, CA, USA Eternygen is attending the Biotech Showcase conference […]
Meet Eternygen at BioEurope conference in Hamburg from November 11th to 13th 2019
Meet Eternygen at BioEurope conference in Hamburg from November 11th to 13th Eternygen will attend the BioEurope conference in Hamburg […]
Prof. Birkenfeld was appointed as Chair of Medicine and Director of the Department of Diabetology, Endocrinology and Nephrology at the University Clinic Tübingen
Prof. Birkenfeld was appointed as Chair of Medicine and Director of the Department of Diabetology, Endocrinology and Nephrology at the […]
Prof. Birkenfeld was awarded with the Abstract Award
Prof. Birkenfeld was awarded with the Abstract Award Prof. Birkenfeld was awarded with the Abstract Award by the American College […]
Eternygen at BioFIT 2017
Eternygen at BioFIT 2017 Eternygen was invited to join panel discussion at BioFIT 2017 conference “How are collaborations key to […]
Prof. Birkenfeld is chairman of the working group diabetes and heart
Prof. Birkenfeld is chairman of the working group diabetes and heart Prof. Birkenfeld is the new chairman of the working […]
Eternygen GmbH is part of the Network for Pharma Solutions (NetPhaSol, Germany)
Eternygen GmbH is part of the Network for Pharma Solutions (NetPhaSol, Germany) Press release
Eternygen GmbH closes € 8.0 (US$ 8.3) million Series A financing
Eternygen GmbH closes € 8.0 (US$ 8.3) million Series A financing Eternygen GmbH Closes € 8.0 (US$ 8.3) million Series […]
Prof. Jordan takes on position as Head of the Institute of Aerospace Medicine
Prof. Jordan takes on position as Head of the Institute of Aerospace Medicine “Prof. Jordan takes on position as Head […]
TransCampus Network between TU Dresden and King’s College London receives €5million grant
TransCampus Network between TU Dresden and King’s College London receives €5million grant The TransCampus network between King’s and Technische Universität […]
Eteryngen at 7th International IQPC Conference
Eteryngen at 7th International IQPC Conference Eternygen GmbH today announced that its head of research will present at the 7th International […]
Prof. Birkenfeld to take over the succession of Prof. Markolf Hanefeld at centre of clinical studies in Dresden
Prof. Birkenfeld to take over the succession of Prof. Markolf Hanefeld at centre of clinical studies in Dresden Interview by […]
Prof. Jordan receives renowned Peter Sleight Award
Prof. Jordan receives renowned Peter Sleight Award Prof. Jordan receives renowned Peter Sleight Award of the european society of Hypertension […]
Prof. Birkenfeld to receive renowned Ferdinand Bertram price
Prof. Birkenfeld to receive renowned Ferdinand Bertram price Press statement of GWT (in German) Article in Sächsische Zeitung (in German)